##semicolon##
хроническая сердечная недостаточность, метаболический синдром, воспаление, ожирение.##submission.citations##
Kernan W., et al. Adipokines and cardiometabolic risk in obesity: mechanistic links and therapeutic implications. Nature Reviews Endocrinology. 2020; 16(6):331–347.
Kraigher-Krainer E., et al. Visceral fat, inflammation and diastolic dysfunction. J Am Coll Cardiol. 2020;75(10):1234–1248.
Packer M. Epicardial and perivascular adipose tissue inflammation in HFpEF: a new paradigm. JACC. 2021;77(20):2638–2648.
Ruiz-Hurtado G., et al. Adiponectin, leptin and resistin in heart failure: mechanistic and clinical insights. Cardiovasc Drugs Ther. 2021;35(4):575–589.